Antioxidant, selenium and risk of nonalcoholic fatty liver disease, more than causality

Chen L, Fan Z, Sun X, Qiu W, Mu W, Chai K, Cao Y, Wang G, Lv G. Diet-derived antioxidants and nonalcoholic fatty liver disease: a Mendelian randomization study. Hepatol Int. 2022.

Zuber V, Grinberg NF, Gill D, Manipur I, Slob EAW, Patel A, et al. Combining evidence from Mendelian randomization and colocalization: review and comparison of approaches. Am J Hum Genet. 2022;5(109):767–782

Article  Google Scholar 

Anstee QM, Darlay R, Cockell S, Meroni M, Govaere O, Tiniakos D, et al. Corrigendum to: “Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort” (J Hepatol [2020] 505–515). J Hepatol. 2021;74:1274–1275

Article  PubMed  Google Scholar 

Mi J, Jiang L, Liu Z, Wu X, Zhao N, Wang Y, et al. Identification of blood metabolites linked to the risk of cholelithiasis: a comprehensive Mendelian randomization study. Hepatol Int. 2022;16:1484–1493

Article  PubMed  Google Scholar 

Chen L, Fan Z, Zhao Y, Yang H, Lv G. Genetic factors in the clinical predictive model for hepatocellular carcinoma: Evidence from genetic association analyses. J Hepatol. 2023.

留言 (0)

沒有登入
gif